A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research

Por O’Daniel, Julianne M., Berg, Jonathan S.
Publicado no Genome Med (2016)

Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings

Por Haga, Susanne B., Tindall, Genevieve, O'Daniel, Julianne M.
Publicado em 2012

Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings

Por Haga, Susanne B., Tindall, Genevieve, O'Daniel, Julianne M.
Publicado em 2012

Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing

Por Haga, Susanne B., O’Daniel, Julianne M., Tindall, Genevieve M., Lipkus, Isaac R., Agans, Robert
Publicado em 2011

Public Attitudes Towards Ancillary Information Revealed by Pharmacogenetic Testing Under Limited Information Conditions

Por Haga, Susanne B., O’Daniel, Julianne M., Tindall, Genevieve M., Lipkus, Isaac R., Agans, Robert
Publicado em 2011

Survey of Genetic Counselors and Clinical Geneticists’ Use and Attitudes Towards Pharmacogenetic Testing

Por Haga, Susanne B., O’Daniel, Julianne M., Tindall, Genevieve M., Mills, Rachel, Lipkus, Isaac M., Agans, Robert
Publicado em 2012

Promoting Public Awareness and Engagement in Genome Sciences

Por Haga, Susanne B., Rosanbalm, Katie D., Boles, Larry, Tindall, Genevieve M., Livingston, Troy M., O'Daniel, Julianne M.
Publicado em 2013

Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling

Por Haga, Susanne B., Carrig, Madeline M., O’Daniel, Julianne M., Orlando, Lori A., Killeya-Jones, Ley A., Ginsburg, Geoffrey S., Cho, Alex
Publicado em 2011

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design

Por Cho, Alex H, Killeya-Jones, Ley A, O'Daniel, Julianne M, Kawamoto, Kensaku, Gallagher, Patrick, Haga, Susanne, Lucas, Joseph E, Trujillo, Gloria M, Joy, Scott V, Ginsburg, Geoffrey S
Publicado em 2012

Is Incidental Finding the Best Term? A Study of Patients’ Preferences

Por Tan, Nina, Amendola, Laura M, O’Daniel, Julianne M., Burt, Amber, Horike-Pyne, Martha J., Boshe, Lacey, Henderson, Gail E., Rini, Christine, Roche M.S., Myra I., Hisama, Fuki M., Burke, Wylie, Wilfond, Benjamin, Jarvik, Gail P.
Publicado no Genet Med (2016)

ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing

Por Green, Robert C., Berg, Jonathan S., Grody, Wayne W., Kalia, Sarah S., Korf, Bruce R., Martin, Christa L., McGuire, Amy, Nussbaum, Robert L., O’Daniel, Julianne M., Ormond, Kelly E., Rehm, Heidi L., Watson, Michael S., Williams, Marc S., Biesecker, Leslie G.
Publicado em 2013

Germline Analysis from Tumor-Germline Sequencing Dyads to identify clinically actionable secondary findings

Por Seifert, Bryce A., O'Daniel, Julianne M., Amin, Krunal, Marchuk, Daniel S., Patel, Nirali M., Parker, Joel S., Hoyle, Alan P., Mose, Lisle E., Marron, Andrew, Hayward, Michele C., Bizon, Christopher, Wilhelmsen, Kirk C., Evans, James P., Earp, H. Shelton, Sharpless, Norman E., Hayes, D. Neil, Berg, Jonathan S.
Publicado no Clin Cancer Res (2016)

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

Por Berg, Jonathan S., Foreman, Ann Katherine M., O'Daniel, Julianne M., Booker, Jessica K., Boshe, Lacey, Carey, Timothy, Crooks, Kristy R., Jensen, Brian C., Juengst, Eric T., Lee, Kristy, Nelson, Daniel K., Powell, Bradford C., Powell, Cynthia M., Roche, Myra I., Skrzynia, Cecile, Strande, Natasha T., Weck, Karen E., Wilhelmsen, Kirk C., Evans, James P.
Publicado no Genet Med (2016)